Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bae, Ok-Nam | - |
| dc.contributor.author | Noh, Minsoo | - |
| dc.contributor.author | Chun, Young-Jin | - |
| dc.contributor.author | Jeong, Tae Cheon | - |
| dc.date.accessioned | 2021-06-22T20:42:16Z | - |
| dc.date.available | 2021-06-22T20:42:16Z | - |
| dc.date.created | 2021-01-21 | - |
| dc.date.issued | 2015-01 | - |
| dc.identifier.issn | 1976-9148 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/19226 | - |
| dc.description.abstract | Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | 한국응용약물학회 | - |
| dc.title | Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Bae, Ok-Nam | - |
| dc.identifier.doi | 10.4062/biomolther.2014.102 | - |
| dc.identifier.scopusid | 2-s2.0-84920054570 | - |
| dc.identifier.wosid | 000347510400002 | - |
| dc.identifier.bibliographicCitation | Biomolecules & Therapeutics, v.23, no.1, pp.12 - 18 | - |
| dc.relation.isPartOf | Biomolecules & Therapeutics | - |
| dc.citation.title | Biomolecules & Therapeutics | - |
| dc.citation.volume | 23 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 12 | - |
| dc.citation.endPage | 18 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART001944939 | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | PERMEABILITY FACTOR | - |
| dc.subject.keywordPlus | FACTOR EXPRESSION | - |
| dc.subject.keywordPlus | ULTRAVIOLET-B | - |
| dc.subject.keywordPlus | VEGF-C | - |
| dc.subject.keywordPlus | FACTOR GENE | - |
| dc.subject.keywordPlus | FACTOR RECEPTORS | - |
| dc.subject.keywordPlus | FACTOR VPF/VEGF | - |
| dc.subject.keywordPlus | PROTEIN-KINASE | - |
| dc.subject.keywordPlus | UVB RADIATION | - |
| dc.subject.keywordPlus | UP-REGULATION | - |
| dc.subject.keywordAuthor | Vascular endothelial growth factor (VEGF) | - |
| dc.subject.keywordAuthor | Biomarker | - |
| dc.subject.keywordAuthor | Keratinocytic damage | - |
| dc.subject.keywordAuthor | Dermal toxicity | - |
| dc.identifier.url | https://www.biomolther.org/journal/view.html?volume=23&number=1&spage=12&year=2015 | - |
- Files in This Item
- Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Bae, Ok Nam
- COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)